Cargando…

Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China

PURPOSE: Estimated glomerular filtration rate (eGFR) decline in HIV-1-infected patients exposure to tenofovir disoproxil fumarate (TDF) has been widely assessed using linear models, but nonlinear assumption is not well validated. We constructed a retrospective cohort study to assess whether eGFR dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Xu, Aifang, Zhao, Huaqing, Yang, Zongxing, Chen, Chen, Ranieri, Brona, Bao, Jianfeng, Zheng, Guoxiang, Wang, Miaochan, Wang, Ying, Xun, Yunhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173951/
https://www.ncbi.nlm.nih.gov/pubmed/32368069
http://dx.doi.org/10.2147/TCRM.S243913
_version_ 1783524540606840832
author Liu, Fang
Xu, Aifang
Zhao, Huaqing
Yang, Zongxing
Chen, Chen
Ranieri, Brona
Bao, Jianfeng
Zheng, Guoxiang
Wang, Miaochan
Wang, Ying
Xun, Yunhao
author_facet Liu, Fang
Xu, Aifang
Zhao, Huaqing
Yang, Zongxing
Chen, Chen
Ranieri, Brona
Bao, Jianfeng
Zheng, Guoxiang
Wang, Miaochan
Wang, Ying
Xun, Yunhao
author_sort Liu, Fang
collection PubMed
description PURPOSE: Estimated glomerular filtration rate (eGFR) decline in HIV-1-infected patients exposure to tenofovir disoproxil fumarate (TDF) has been widely assessed using linear models, but nonlinear assumption is not well validated. We constructed a retrospective cohort study to assess whether eGFR decline follows nonlinearity during antiviral therapy. PATIENTS AND METHODS: We examined 823 (299 of TDF users and 524 of non-TDF users) treatment-naïve HIV-1-infected participants (age ≥ 17 years, initial eGFR ≥ 90 mL/min/1.73m(2)). Estimated GFR trajectories were compared by one-linear and piecewise-linear mixed effects models, before and after propensity score matching, respectively. Whether the incidence of renal dysfunction (reduced renal function [RRF], eGFR < 90 mL/min/1.73 m(2) and rapid kidney function decline [RKFD], eGFR > −3 mL/min/1.73 m(2)/year) follows nonlinearity was assessed by logistic regression. RESULTS: The median follow-up time of this study was 10 (interquartile range, 2–20) months, during which 178 (21.6%) experienced RRF, and 451 (54.8%) experienced RKFD. The slopes (mL/min/1.73 m(2)/year) of eGFR were −5.31 (95% CI: −6.57, −4.06) before 1.40 years, 4.83 (95% CI: 1.38, 8.28) from years 1.40 to 2.30 and −3.71 (95% CI: −5.97, −1.45) after 2.30 years among TDF users. Within years 1.40–2.30, each year of TDF exposure was associated with a 78% decreased risk of RKFD (95% CI: −91%, −49%). In comparison, eGFR increased slightly at the initiation of antiviral therapy, declined after 2.15 years (−4.96; 95% CI: −5.76, −4.17) among non-TDF users. Such a progression nonlinear trajectory was missed on the assumption of one-linearity, whether in TDF or non-TDF users. CONCLUSION: Over the piecewise mixed-effects analyses with the advantage of revealing the true nature of the exposure outcome relationships, an interesting reverse S-shaped relationship was observed. A routine screen based on nonlinearity could be more helpful for patient management.
format Online
Article
Text
id pubmed-7173951
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71739512020-05-04 Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China Liu, Fang Xu, Aifang Zhao, Huaqing Yang, Zongxing Chen, Chen Ranieri, Brona Bao, Jianfeng Zheng, Guoxiang Wang, Miaochan Wang, Ying Xun, Yunhao Ther Clin Risk Manag Original Research PURPOSE: Estimated glomerular filtration rate (eGFR) decline in HIV-1-infected patients exposure to tenofovir disoproxil fumarate (TDF) has been widely assessed using linear models, but nonlinear assumption is not well validated. We constructed a retrospective cohort study to assess whether eGFR decline follows nonlinearity during antiviral therapy. PATIENTS AND METHODS: We examined 823 (299 of TDF users and 524 of non-TDF users) treatment-naïve HIV-1-infected participants (age ≥ 17 years, initial eGFR ≥ 90 mL/min/1.73m(2)). Estimated GFR trajectories were compared by one-linear and piecewise-linear mixed effects models, before and after propensity score matching, respectively. Whether the incidence of renal dysfunction (reduced renal function [RRF], eGFR < 90 mL/min/1.73 m(2) and rapid kidney function decline [RKFD], eGFR > −3 mL/min/1.73 m(2)/year) follows nonlinearity was assessed by logistic regression. RESULTS: The median follow-up time of this study was 10 (interquartile range, 2–20) months, during which 178 (21.6%) experienced RRF, and 451 (54.8%) experienced RKFD. The slopes (mL/min/1.73 m(2)/year) of eGFR were −5.31 (95% CI: −6.57, −4.06) before 1.40 years, 4.83 (95% CI: 1.38, 8.28) from years 1.40 to 2.30 and −3.71 (95% CI: −5.97, −1.45) after 2.30 years among TDF users. Within years 1.40–2.30, each year of TDF exposure was associated with a 78% decreased risk of RKFD (95% CI: −91%, −49%). In comparison, eGFR increased slightly at the initiation of antiviral therapy, declined after 2.15 years (−4.96; 95% CI: −5.76, −4.17) among non-TDF users. Such a progression nonlinear trajectory was missed on the assumption of one-linearity, whether in TDF or non-TDF users. CONCLUSION: Over the piecewise mixed-effects analyses with the advantage of revealing the true nature of the exposure outcome relationships, an interesting reverse S-shaped relationship was observed. A routine screen based on nonlinearity could be more helpful for patient management. Dove 2020-04-17 /pmc/articles/PMC7173951/ /pubmed/32368069 http://dx.doi.org/10.2147/TCRM.S243913 Text en © 2020 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Fang
Xu, Aifang
Zhao, Huaqing
Yang, Zongxing
Chen, Chen
Ranieri, Brona
Bao, Jianfeng
Zheng, Guoxiang
Wang, Miaochan
Wang, Ying
Xun, Yunhao
Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title_full Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title_fullStr Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title_full_unstemmed Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title_short Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China
title_sort longitudinal progression of estimated gfr in hiv-1-infected patients with normal renal function on tenofovir-based therapy in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173951/
https://www.ncbi.nlm.nih.gov/pubmed/32368069
http://dx.doi.org/10.2147/TCRM.S243913
work_keys_str_mv AT liufang longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT xuaifang longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT zhaohuaqing longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT yangzongxing longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT chenchen longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT ranieribrona longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT baojianfeng longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT zhengguoxiang longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT wangmiaochan longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT wangying longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina
AT xunyunhao longitudinalprogressionofestimatedgfrinhiv1infectedpatientswithnormalrenalfunctionontenofovirbasedtherapyinchina